血性铁和贫血在SARS-CoV-2病变发生过程中的作用
Guillermo Velasco de Cos1, Armando Raul Guerra Ruiz1, C A Amado1
1University Hospital Marqués de Valdecilla, Santander, Spain.
EJIFCC
|October 16, 2025
概括
患有COVID-19和缺铁性贫血 (IDA) 的患者比其他贫血患者有更好的结果. 这项研究强调了评估铁状况对于预测COVID-19预后的重要性.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 内部医学 内部医学
背景情况:
- 贫血在SARS-CoV-2患者中很常见,但其与铁代谢和疾病进展的联系尚未得到充分研究.
- 缺铁性贫血 (IDA) 和其对COVID-19结果的影响需要进一步调查.
研究的目的:
- 分析血红蛋白和红细胞缺铁对COVID-19患者预后的影响.
- 为了比较非贫血,贫血 (非IDA) 和缺铁贫血 (IDA) COVID-19 患者的临床结果.
主要方法:
- 对435名未接种疫苗的COVID-19患者进行了回顾性观察研究.
- 收集了红细胞指数,血红蛋白,炎症标志物和临床结果的数据.
- 将患者分为非贫血,贫血 (非IDA) 和IDA组.
主要成果:
- 贫血患者的临床进展比非贫血患者更差 (病房/ICU入院率更高).
- 与非IDA贫血患者相比,患有IDA的COVID-19患者的结果明显更好 (较低的病房/ICU入院,较短的停留时间).
- IDA患者表现出减少的炎症标志物 (CRP,费里丁) 和IDA是一个独立的保护因素.
结论:
- 铁的状况,特别是IDA,对于评估COVID-19预后至关重要.
- 与其他类型贫血相比,IDA与COVID-19患者的更有利结果有关.
- 在调整了诸如年龄,性别和并发症等混因素后,IDA的保护作用仍然存在.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.3K
相关概念视频
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Pneumonia II: Pathophysiology
2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K
Erythropoiesis
5.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Hemoglobin
7.4K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
7.4K
